ES427956A1 - Procedimiento de preparacion del 2-(p-clorofenoxi)-2,2-di- metilacetato de (6'-(n-metilaminocarboniloximetil) - 2' - piridil)-metilo y sus sales de adicion con un acido organicoo mineral. - Google Patents
Procedimiento de preparacion del 2-(p-clorofenoxi)-2,2-di- metilacetato de (6'-(n-metilaminocarboniloximetil) - 2' - piridil)-metilo y sus sales de adicion con un acido organicoo mineral.Info
- Publication number
- ES427956A1 ES427956A1 ES427956A ES427956A ES427956A1 ES 427956 A1 ES427956 A1 ES 427956A1 ES 427956 A ES427956 A ES 427956A ES 427956 A ES427956 A ES 427956A ES 427956 A1 ES427956 A1 ES 427956A1
- Authority
- ES
- Spain
- Prior art keywords
- preparation
- processes
- pharmaceutical compositions
- pyridine derivative
- methylaminocarbonyloxymethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003222 pyridines Chemical class 0.000 title 1
- 206010003210 Arteriosclerosis Diseases 0.000 abstract 1
- 102000015081 Blood Coagulation Factors Human genes 0.000 abstract 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 208000037849 arterial hypertension Diseases 0.000 abstract 1
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract 1
- 239000003114 blood coagulation factor Substances 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7324737A FR2244511B1 (enExample) | 1973-07-05 | 1973-07-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES427956A1 true ES427956A1 (es) | 1976-12-01 |
Family
ID=9122139
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES427956A Expired ES427956A1 (es) | 1973-07-05 | 1974-07-04 | Procedimiento de preparacion del 2-(p-clorofenoxi)-2,2-di- metilacetato de (6'-(n-metilaminocarboniloximetil) - 2' - piridil)-metilo y sus sales de adicion con un acido organicoo mineral. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US3971798A (enExample) |
| JP (1) | JPS5037783A (enExample) |
| AR (1) | AR201955A1 (enExample) |
| AT (1) | ATA555874A (enExample) |
| AU (1) | AU7072074A (enExample) |
| BE (1) | BE817211A (enExample) |
| DE (1) | DE2432322A1 (enExample) |
| DK (1) | DK361674A (enExample) |
| ES (1) | ES427956A1 (enExample) |
| FI (1) | FI203574A7 (enExample) |
| FR (1) | FR2244511B1 (enExample) |
| GB (1) | GB1426666A (enExample) |
| LU (1) | LU70459A1 (enExample) |
| NL (1) | NL7409178A (enExample) |
| NO (1) | NO742431L (enExample) |
| OA (1) | OA04727A (enExample) |
| SE (1) | SE7408820L (enExample) |
| ZA (1) | ZA744205B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6083497A (en) | 1997-11-05 | 2000-07-04 | Geltex Pharmaceuticals, Inc. | Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers |
| AU2016215179B2 (en) | 2015-02-06 | 2021-02-25 | Intercept Pharmaceuticals, Inc. | Pharmaceutical compositions for combination therapy |
| CA3142358A1 (en) | 2019-05-30 | 2020-12-03 | Intercept Pharmaceuticals, Inc. | Pharmaceutical compositions comprising a fxr agonist and a fibrate for use in the treatment of cholestatic liver disease |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1498459A (enExample) * | 1965-07-30 | 1968-01-08 | ||
| JPS4430271Y1 (enExample) * | 1966-02-22 | 1969-12-13 |
-
1973
- 1973-07-05 FR FR7324737A patent/FR2244511B1/fr not_active Expired
-
1974
- 1974-06-25 OA OA55228A patent/OA04727A/xx unknown
- 1974-07-01 ZA ZA00744205A patent/ZA744205B/xx unknown
- 1974-07-01 AR AR254512A patent/AR201955A1/es active
- 1974-07-02 US US05/485,244 patent/US3971798A/en not_active Expired - Lifetime
- 1974-07-02 AU AU70720/74A patent/AU7072074A/en not_active Expired
- 1974-07-03 FI FI2035/74A patent/FI203574A7/fi unknown
- 1974-07-03 LU LU70459A patent/LU70459A1/xx unknown
- 1974-07-03 BE BE146181A patent/BE817211A/xx unknown
- 1974-07-04 NO NO742431A patent/NO742431L/no unknown
- 1974-07-04 ES ES427956A patent/ES427956A1/es not_active Expired
- 1974-07-04 JP JP49075934A patent/JPS5037783A/ja active Pending
- 1974-07-04 SE SE7408820A patent/SE7408820L/xx unknown
- 1974-07-05 DE DE2432322A patent/DE2432322A1/de active Pending
- 1974-07-05 DK DK361674A patent/DK361674A/da unknown
- 1974-07-05 NL NL7409178A patent/NL7409178A/xx unknown
- 1974-07-05 GB GB2995674A patent/GB1426666A/en not_active Expired
- 1974-07-05 AT AT555874A patent/ATA555874A/de not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU7072074A (en) | 1976-01-08 |
| ZA744205B (en) | 1976-02-25 |
| BE817211A (fr) | 1975-01-03 |
| OA04727A (fr) | 1980-08-31 |
| AR201955A1 (es) | 1975-04-30 |
| DK361674A (enExample) | 1975-03-03 |
| FR2244511B1 (enExample) | 1977-07-15 |
| NL7409178A (nl) | 1975-01-07 |
| US3971798A (en) | 1976-07-27 |
| SE7408820L (enExample) | 1975-01-07 |
| FR2244511A1 (enExample) | 1975-04-18 |
| ATA555874A (de) | 1976-08-15 |
| DE2432322A1 (de) | 1975-01-30 |
| LU70459A1 (enExample) | 1975-03-27 |
| FI203574A7 (enExample) | 1975-01-06 |
| NO742431L (enExample) | 1975-02-03 |
| JPS5037783A (enExample) | 1975-04-08 |
| GB1426666A (en) | 1976-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2372175A1 (fr) | Procede de preparation de l'hydroxy-3 androstanone-17 et de l'hydroxy-3 androstene-5 one-17 | |
| IE810315L (en) | Indane derivatives | |
| ES474234A1 (es) | Un procedimiento para preparar compuestos de 1,4-dihidropi- ridina sustituidos en posicion 6 | |
| GB2023600B (en) | Imadazole derivatives process for their preparation and pharmaceutical preparations containing them | |
| IE42977L (en) | Triaryl-piperidine methanols. | |
| GB1528723A (en) | 1-nitro-9-n-substituted aminoalkylamino-acridines their salts and a method of preparing same | |
| FR2355797A1 (fr) | Procede de preparation de vinylcyclopropanes substitues utilisables dans la preparation d'insecticides | |
| ES427956A1 (es) | Procedimiento de preparacion del 2-(p-clorofenoxi)-2,2-di- metilacetato de (6'-(n-metilaminocarboniloximetil) - 2' - piridil)-metilo y sus sales de adicion con un acido organicoo mineral. | |
| IE34665B1 (en) | Isothioureas and their derivatives | |
| ES475361A1 (es) | Procedimiento para preparar un nuevo derivado de piridina | |
| SE7704829L (sv) | Indazolyl-(4)-oxi-propanolaminer | |
| US3322631A (en) | Method of treatment of hypertension | |
| MY102991A (en) | Medicaments for treating hypertension. | |
| GB1268956A (en) | Derivatives of 2-(halophenoxy or halophenylthio) alkanamides and their preparation | |
| IE33371B1 (en) | Protozoacidally-active substituted guanidines | |
| SE7600801L (sv) | Forfarande for framstellning av 4-(4-bifenylyl)-butanoler | |
| GB1497729A (en) | Benzenesulphonyl ureas and process for their manufacture | |
| FR2387959A1 (fr) | Procede de preparation de pyridoxine | |
| GB1246117A (en) | Pharmaceutical preparations containing glucose compounds, glucose derivatives and process for their manufacture | |
| GB1500300A (en) | Pharmaceutical preparation for the treatment of circulatory disorders | |
| ATE53030T1 (de) | Verbindung mit entzuendungshemmender wirkung, verfahren zu ihrer herstellung und pharmazeutische praeparate die sie enthalten. | |
| IE781519L (en) | 1-phenylethanolamine derivatives | |
| DE3580888D1 (de) | 2-aminothiazolderivate die eine saeureausscheidungshemmende wirkung besitzen. | |
| IE39658L (en) | N-substituted glycinate pharmaceuticals | |
| FR2366279A1 (fr) | Acides 5-alkoxy-picoliniques, procede pour leur preparation et composition anti-hypertensive contenant des acides 5-alkoxy-picolinique |